Dr.Fitzpatrick Interviewed by Scientific American
In an interview with the Scientific American, Dr. Anthony Fitzpatrick discusses the signficance of structural diversity in tauopathy strains and their implications in developing therapeutic targets for disease.
Tau Shows Promise as Achilles’ Heel for Alzheimer’s and Similar Diseases